CareMax, Inc., a health care organization, provides medical services through physicians and health care professionals. The company offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health & wellness, optometry, dental, pharmacy and transportation. As of June 30, 2021, it owned and operated 36 multi-specialty medical care centers throughout Miami-Dade, Broward, and Orange Counties in Florida. The company is headquartered in Miami, Florida.
IPO Year: 2020
Exchange: NASDAQ
Website: caremax.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/26/2024 | $1.50 → $7.50 | Buy → Hold | Jefferies |
11/17/2023 | $5.00 → $1.00 | Buy → Neutral | UBS |
11/10/2023 | $3.00 → $2.00 | Overweight → Neutral | Piper Sandler |
3/17/2023 | $7.00 → $4.00 | Outperform → Market Perform | TD Cowen |
9/7/2022 | $7.50 | Hold | Truist |
1/7/2022 | $14.00 | Buy | UBS |
10/20/2021 | $15.00 | Buy | Jefferies |
9/13/2021 | $14.00 | Neutral → Overweight | Piper Sandler |
9/13/2021 | Neutral → Overweight | Piper Sandler | |
9/10/2021 | $14.00 | Outperform | Cowen & Co. |
3 - CareMax, Inc. (0001813914) (Issuer)
3 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
NT 10-Q - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
Jefferies downgraded CareMax from Buy to Hold and set a new price target of $7.50 from $1.50 previously
UBS downgraded CareMax from Buy to Neutral and set a new price target of $1.00 from $5.00 previously
Piper Sandler downgraded CareMax from Overweight to Neutral and set a new price target of $2.00 from $3.00 previously
TD Cowen downgraded CareMax from Outperform to Market Perform and set a new price target of $4.00 from $7.00 previously
Truist initiated coverage of CareMax with a rating of Hold and set a new price target of $7.50
UBS initiated coverage of CareMax with a rating of Buy and set a new price target of $14.00
Jefferies initiated coverage of CareMax with a rating of Buy and set a new price target of $15.00
Piper Sandler upgraded CareMax from Neutral to Overweight and set a new price target of $14.00
Piper Sandler upgraded CareMax from Neutral to Overweight
Cowen & Co. initiated coverage of CareMax with a rating of Outperform and set a new price target of $14.00